72 week data of the HIDIT-1 trial: A multicenter randomised study comparing peginterferon alpha-2a plus adefovir vs. peginterferon alpha-2a plus placebo vs. adefovir in chronic delta hepatitis

Author
Drebber, U.
Manns, M. P.
Bozkaya, H.
Meyer, S.
Dienes, H. P.
Wedemeyer, H.
Yurdaydin, C.
Dalekos, G.
Erhardt, A.
Cakaloglu, Y.
Degertekin, H.
Gurel, S.
Zeuzem, S.
Bock, T.
Zachou, K.
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/84000
https://doi.org/10.1016/s0168-8278(07)61602-x
Collections